Biotechnology
The delicate dance of developmental genes
Research
EPFL
Using CRISPR technology, researchers at EPFL and the University of Geneva have uncovered the complex dance of genes involved in embryonic development.
The protein engineer
TechTransfer
ETH Zurich
Tom Edwardson modified a tiny artificial protein structure so it could be used as a vehicle for RNA molecules and other active substances. He now aims to create a spin-off to bring his development to market.
Sensing the brain’s chemical signals
Research
ETH Zurich
Nako Nakatsuka earned a place on this year’s MIT Technology Review’s Innovators Under 35 list for her invention of a precise chemical biosensor that empowers researchers to better understand brain processes and diseases such as Alzheimer’s, Major Depression, and Parkinson’s.
Faulty regulation of an architect gene can lead to rare bone disease
Research
EPFL
EPFL researchers found that, if expressed too early during embryonic development, one of the genes that orchestrate the formation of limbs can lead to a rare disorder of bone growth.
Computer algorithms are currently revolutionising biology
Research
ETH Zurich
Artificial intelligence can help predict the three-dimensional structure of proteins. Beat Christen describes how such algorithms should soon help to develop tailored artificial proteins.
Lung cancer: Hope for increasing immunotherapy efficacy
Research
EPFL
A “paradox and setback” forced EPFL scientists to dig deeper when seeking a means to boost the power of immunotherapy in lung cancer. Understanding the problem – and finding the solution – has led to a promising potential therapy for some patients.
Page 7 of 9